Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting placebo or sham interventions. |
Full bibliographic reference | Howick J, Webster RK, Rees J, Turner R, Macdonald H, 1. Price A, Evers WMA, Bishop FL, Collins GS, Bokelmann K, Hopewell S, Knottnerus A, Lamb S, Madigan C, Napadow V, Papanikitas A, Hoffmann T. TIDieR-Placebo: a guide and checklist for reporting placebo and sham controls. PLoS Med. 2020;17(9):e1003294. |
Language | English |
PubMed ID | 32956344 |
Relevant URLs (full-text if available) |
The full-text of the TIDieR-Placebo reporting guideline can be accessed at: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003294 |
Relevant more generic / specialised reporting guidelines (i.e. main generic guideline or extension to a generic guideline) |
Generic TIDieR: Hoffmann T, Glasziou P, Boutron I, Milne R, Perera R, Moher D, Altman D, Barbour V, Macdonald H, Johnston M, Lamb S, Dixon-Woods M, McCulloch P, Wyatt J, Chan A, Michie S. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. PMID: 24609605 Specialisd TIDieR-PHP: Campbell M, Katikireddi SV, Hoffmann T, Armstrong R, Waters E, Craig P. TIDieR-PHP: a reporting guideline for population health and policy interventions. BMJ. 2018;361:k1079. PMID: 29769210 |
Reporting guideline website URL | http://www.tidierguide.org/ |
Reporting guideline acronym | TIDieR-Placebo |
Study design | Clinical trials, Experimental studies, Observational studies, Study protocols, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews |
Applies to the whole report or to individual sections of the report? | Intervention (exposure) |
Additional information | Read the TIDieR Placebo Protocol (PDF). Read a background paper: Howick J, Hoffmann T. How placebo characteristics can influence estimates of intervention effects in trials. CMAJ. 2018;190(30):E908-E911. PMID: 30061325 |
Record last updated on | September 8, 2021 |